Cryoablation. It’s Your Choice

Hear Why Patients Choose Cryoablation with IceCure

“There’s no pain. I was apprehensive that morning but there was no reason to be. When we left there, there was no pain. I went home, we had a regular dinner and I’ve never looked back.”
Breast Cancer* Patient Pam Dixon, ICE3 Trial Participant, USA 

*The FDA has not yet granted ProSense clearance for the treatment of breast cancer. Please refer to your country’s user manual for a list of approved indications in your region. **This image is not of a real patient.

Cryoablation. It’s Your Choice

Hear why patients choose cryoablation with IceCure

“There’s no pain. I was apprehensive that morning but there was no reason to be. When we left there, there was no pain. I went home, we had a regular dinner and I’ve never looked back.”
Patient Pam Dixon, ICE3 Trial Participant, USA 

*The FDA has not yet granted ProSense clearance for the treatment of breast cancer. Please refer to your country’s user manual for a list of approved indications in your region. **This image is not of a real patient.

Choose What is Right
for You

At IceCure, we believe in empowering patients to have a choice in their tumor treatment. We understand that everyone is unique and there is no one size treatment that fits all. We believe that by offering a minimally invasive option through cryoablation, which destroys tumors by freezing them, we can help turn an often daunting experience into a hopeful and restorative one.

The ProSense Cryoablation System delivers on our mission of patient choice by offering outstanding results with a minimally invasive, effective, and comfortable treatment experience for benign and cancerous tumors.

Choose Cryoablation for Breast Tumors

Breast remains whole

No tissue is removed and only a small nick is made in the skin. 100% of patients satisfied with ProSense™ procedure*

Low risk of complications

Minimally invasive procedure vs. higher-risk surgical procedures

Fast procedure

Typically takes about an hour

Rapid recovery

Get back to daily activities immediately

Recovery

Minimal pain and discomfort

Local anesthesia & cooling from ice reduces pain

In-office treatments

In-office treatment

No hospital admission and waiting

Promising results in the cryoablation treatment of breast cancer*

96.3%

of patients were free from local recurrence who were treated with ProSense™ and received hormone therapy*

*The ICE3 study is the largest controlled multi-location clinical trial ever completed for cryoablation of small, low-risk breast cancer.
The breast cancer indication for the ProSense System is currently under review by the FDA and has not yet received marketing clearance in the US. ProSense is cleared for the treatment of breast cancer in select markets; please review to your country’s user manual for a list of approved indications in your region.

Choose Cryoablation for Cancer 

Learn more about the full range of clinical treatment applications for the ProSense Cryoblation System  

How does Cryoablation Work?

Cryoablation uses ultra-cold temperatures to freeze and destroy tumors. Typically, the entire process generally takes about an hour under local anesthesia or light sedation, allowing patients to quickly resume their daily lives.

  • A thin cryoprobe, resembling a needle, is inserted into the targeted tissue with the guidance of ultrasound imaging or CT
  • Liquid nitrogen, at ultra-cold temperatures, flows through the cryoprobe in a closed loop system, creating an ice ball to form around the tumor. A freeze-thaw-freeze cycle is performed to ensure thorough tumor destruction
  • Once the final thaw step is completed, the cryoprobe is removed, and a small incision is covered with a steri-strip or band-aid. Over time, the body naturally eliminates the necrotic debris left behind from the destroyed tumor
Video - How Does Cryoablation Work? 

Resources

Webinars

Webinar: Cryoablation in the Thoracic Cavity

This webinar lead by Dr. Julien Frandon of the Department of Radiology at CHU de Nîmes discusses various cases performed with the ProSense™ Liquid Nitrogen (LN2) Based Cryoablation System in the thoracic cavity (i.e. lung, mediastinum). (60 minutes)

Read More >

Publications

Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions

The aim of this retrospective study was to assess the feasibility of the IceCure’s single-probe liquid nitrogen system for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique.

Read More >

Publications

Cryoablation Using Liquid Nitrogen for Metastatic Lung Cancers

This retrospective observational study conducted by Professor Hiroaki Nomori, MD found that cryoablation using liquid nitrogen would be one of the treatment methods for metastatic lung cancers <2.2 cm; and pulmonary function decreased significantly when cryoablation was performed for an

Read More >